Cargando…
Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery
Asthma and chronic obstructive pulmonary disease (COPD) are pulmonary diseases that are characterized by inflammatory cell infiltration, cytokine production, and airway hyper-reactivity. Most of the effector cells responsible for these pathologies reside in the lungs. One of the most direct ways to...
Autores principales: | Chiang, Po-Chang, Alsup, Jason W, Lai, Yurong, Hu, Yiding, Heyde, Bruce R, Tung, David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894320/ https://www.ncbi.nlm.nih.gov/pubmed/20596335 http://dx.doi.org/10.1007/s11671-008-9234-1 |
Ejemplares similares
-
Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery
por: Chiang, Po-Chang, et al.
Publicado: (2011) -
Evaluating the Suitability of Using Rat Models for Preclinical Efficacy and Side Effects with Inhaled Corticosteroids Nanosuspension Formulations
por: Chiang, Po-Chang, et al.
Publicado: (2010) -
Comparison of In vitro Nanoparticles Uptake in Various Cell Lines and In vivo Pulmonary Cellular Transport in Intratracheally Dosed Rat Model
por: Lai, Yurong, et al.
Publicado: (2008) -
Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity
por: Chiang, Po-Chang, et al.
Publicado: (2014) -
Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment
por: Wahlstrom, Jan L, et al.
Publicado: (2007)